Jacob Sands, MD is a thoracic medical oncologist at the Dana-Farber Cancer Institute where he treats patients with lung cancer and performs clinical research on lung cancer diagnostics and therapeutics. He leads the clinical small cell lung cancer program at the Dana-Farber Cancer Institute and serves on the NCCN guidelines committee for small cell lung cancer. Dr. Sands is a member of the Brigham and Women’s Hospital CT lung screening program and was a member of the Lahey CT lung screening steering committee while working there as a medical oncologist. He is a member of the NCCN guidelines committee on CT lung screening and the IASLC Screening & Early Detection Committee. Dr. Sands is a scientific advisory board member of the GO2 Foundation for Lung Cancer, a media spokesperson for the American Lung Association, and Treasurer of the Rescue Lung Rescue Life Society, a medical society focused on implementing lung screening and pioneering future innovations for early detection.